newsfilter
← Latest News
Business Wire·

Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/hgsi) is investigating potential claims against the board of directors of Human Genome Sciences Inc. (“Human Genome” or the “Company”) (NASDAQ: HGSI) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell Human Genome to GlaxoSmithKline plc in a transaction valued at approximately $3 billion.